Artificial Intelligence in Cardiovascular Care — Part 2: Applications: JACC Review Topic of the Week
Sneha Jain,Pierre Elias,Timothy Poterucha,Michael Randazzo,Francisco Lopez Jimenez,Rohan Khera,Marco Perez,David Ouyang,James Pirruccello,Michael Salerno,Andrew Einstein,Robert Avram,Geoff Tison,Girish Nadkarni,Vivek Natarajan,Emma Pierson,Ashley Beecy,Deepa Kumaraiah,Chris Haggerty,Jennifer N Avari Silva,Thomas M Maddox,Jennifer N. Avari Silva,Thomas M. Maddox
DOI: https://doi.org/10.1016/j.jacc.2024.03.401
IF: 24
2024-04-10
Journal of the American College of Cardiology
Abstract:Recent Artificial Intelligence (AI) advancements in cardiovascular care offer potential enhancements in effective diagnosis, treatment, and outcomes. Over 600 Food and Drug Administration (FDA)-approved clinical AI algorithms now exist, with 10% focusing on cardiovascular applications, highlighting the growing opportunities for AI to augment care. This review discusses the latest advancements in the field of AI, with a particular focus on the utilization of multimodal inputs and the field of generative AI. Further discussions in this review involve an approach to understanding the larger context in which AI-augmented care may exist, and include a discussion of the need for rigorous evaluation, appropriate infrastructure for deployment, ethics and equity assessments, regulatory oversight, and viable business cases for deployment. Embracing this rapidly evolving technology while setting an appropriately high evaluation benchmark with careful and patient-centered implementation will be crucial for cardiology to leverage AI to enhance patient care and the provider experience.
cardiac & cardiovascular systems